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The erosion of a pancreatic pseudocyst into an
adjacent artery is a rare and highly lethal complication
of pancreatitis with reported death rates of 12% to
40%.1-5 Despite improvements in the diagnosis and
management of pancreatic pseudocysts, the incidence
of intracystic hemorrhage ranges from 6% to 17%.6,7
In recent reports, investigators have described the
successful management of pancreatic pseudoa-
neurysms with endovascular techniques and have
advocated percutaneous angiographic embolization
(PAE) as the preferred treatment modality.8,9 This
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Objective: Erosion of pancreatic pseudocysts into adjacent vessels is a rare but highly
lethal cause of intra-abdominal hemorrhage. Percutaneous angiographic embolization
(PAE) of the bleeding artery has recently been advocated as the preferred therapy. This
study was undertaken to survey the outcome after treatment of this complication and to
make recommendations for its management. 
Methods: An 11-year retrospective analysis was performed of all patients treated at a large
tertiary care referral center for visceral artery pseudoaneurysms associated with pancre-
atic pseudocysts.
Results: From 1988 to 1998, 256 patients were admitted for complications of pancreat-
ic pseudocysts. Sixteen patients (11 men and 5 women) were identified in whom a
pseudocyst had eroded into a major blood vessel with hemorrhage or development of a
false aneurysm. The mean age was 45 years (range, 23-67 years). Active bleeding was
present in 13 patients, whereas three had evidence of recent hemorrhage. Ten of 16
patients initially underwent operative therapy, four elective and six emergency, whereas
six stable patients were initially treated with PAE. Technical failures of the initial treat-
ment or secondary complications required both therapeutic modalities in six patients,
which resulted in 13 total surgical interventions and 10 PAEs. The surgical morbidity
rate was 62% (8 of 13), whereas that of PAE was 50% (5 of 10). Three deaths occurred
after emergency operations, two of which failed to stop the bleeding, accounting for all
of the deaths in the series (3 [19%] of 16). A trend was noted toward increased death
with necrotizing pancreatitis (P = .07) and emergency surgery (P = .06). Ranson’s cri-
teria were not found to be predictive of death in this series. Surgical drainage procedures
were required in seven (44%) of 16 patients for infections (n = 3) or mass effect of the
pseudoaneurysm (n = 3). The mean size of pseudoaneurysms that required operative
intervention for secondary complications was 13.9 cm, compared with 7.7 cm for all
others in the series (P = .046). Long-term follow-up was available in all 13 survivors at
a mean of 44 months (range, 1-108 months).
Conclusions: The management of pancreatic pseudocyst-associated pseudoaneurysms
remains a challenging problem with high morbidity and death rates. Operation and PAE
play complementary management roles. PAE is recommended as the initial therapy for
hemodynamically stable patients. Surgery should be reserved for actively bleeding,
hemodynamically unstable patients; for failed embolization; and for other secondary
complications such as infection or extrinsic compression. (J Vasc Surg 2000;32:722-30.)
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study was undertaken to survey the outcome after
treatment of visceral pseudoaneurysms resulting from
pancreatic pseudocysts and to make recommenda-
tions for their management.
PATIENTS AND METHODS
A retrospective chart review was performed for
all patients admitted to the Henry Ford Hospital
from 1988 to 1998 for complications of pancreatic
pseudocysts. We identified 256 patients. Sixteen
(6.3%) patients (11 men and 5 women) with a mean
age of 45 years (range, 23-67 years) were identified
with erosion of a pseudocyst into a major vessel.
Inclusion criterion was the diagnosis of a pseudo-
aneurysm by means of computed tomography (CT),
ultrasound scan, angiography, endoscopy, or intraop-
erative findings. Patients with a visceral pseudo-
aneurysm without a history of pancreatitis were
excluded, as were those with hemorrhagic pancreati-
tis and necrotizing pancreatitis unless the patient had
a documented pseudocyst or pseudoaneurysm. All
available medical records, including hospital and
office charts and imaging study reports, were exam-
ined. Clinical follow-up was complemented by review
of the medical record and telephone contact with the
patient and family or primary care physician.
RESULTS
The etiology of pancreatitis was alcohol in 8
patients, biliary pathology in 2, hypertriglyceridemia
in 2, trauma in 1, and undetermined in 3. Eight
patients had prior episodes of pancreatitis, but
pseudocyst formation and hemorrhage occurred
with the first episode in the remaining eight. Only
three patients had prior pseudocysts.
The method of diagnosis was CT in 12 patients,
endoscopy in 2 in whom blood was seen emanating
from the ampulla of Vater (hemosuccus pancreati-
cus), and exploratory laparotomy in 2. The bleeding
vessel was the gastroduodenal artery (GDA) in six
patients and the splenic artery in three. The superi-
or posterior pancreaticoduodenal artery, the inferior
posterior pancreaticoduodenal artery, the splenic
vein, and the superior mesenteric artery (SMA) were
responsible for hemorrhage in one patient each. In
three patients, the source was undetermined. The
mean size of the pseudoaneurysm was 10 cm (range,
2-33 cm).
Operative intervention as first-line therapy was per-
formed in 10 patients, six emergency and four elective
(Table I). Surgery consisted of ligation or repair of the
bleeding vessel followed by external drainage of the
pseudocyst, Roux-en-Y cystojejunostomy, or distal
pancreatectomy. PAE was performed as the initial ther-
apy in six hemodynamically stable patients who pre-
sented with nonacute abdominal findings (Table II).
Operative indications are listed in Table III.
Death. None of the four patients who presented
with stable hemodynamics and underwent elective
operations died. Of the six patients who underwent
emergency operation, bleeding could not be con-
trolled in three (Table I, patients 1, 2, 3), who then
underwent PAE. In patients 1 and 2, dissection of
the common hepatic artery and celiac axis, respec-
tively, occurred, which resulted in one death (patient
1). The remaining patient (3) underwent a success-
ful PAE of the gastroepiploic artery, but still died.
Patient 4 (the third death) died as a result of hem-
orrhagic shock in the immediate postoperative peri-
od after ligation of the splenic artery, distal pancrea-
tectomy, and splenectomy. The overall death rate
was 19% (3 of 16). Infected necrotizing pancreatitis
was present in two of the three patients. A trend
toward increased death was noted with necrotizing
pancreatitis (P = .07) and emergency surgery (P =
.06). Ranson’s criteria were not found to be predic-
tive of death in this series. Preoperative and preem-
bolization transfusion requirements ranged from 0
to 10 units of packed red blood cells and were not
associated with death.
Technical success rates. In addition to the three
patients who required PAE after the initial failed
operation, one additional patient (5) required
delayed PAE. This patient had undergone right
hemicolectomy, pancreatic debridement, and exter-
nal drainage of a 33-cm pseudoaneurysm; on his
29th postoperative day he hemorrhaged into the
residual cystic cavity from the GDA, which was then
treated by successful coil embolization (Fig 1).
There were six patients treated initially with elec-
tive PAE, of whom three required subsequent opera-
tive therapy. Technical failures occurred in two
patients. In one patient (11), who had an 8-cm
pseudoaneurysm, the bleeding pancreaticoduodenal
artery could not be cannulated, and the patient
underwent external pseudocyst drainage and ligation
of the bleeding vessel. In another patient (15) under-
went Roux-en-Y cystojejunostomy and ligation of
the GDA for persistent bleeding into a 5-cm pancre-
atic pseudocyst after PAE (Fig 2). The third patient
(16) underwent a successful PAE of the GDA for a 6-
cm pseudoaneurysm; however, 17 days later the
patient had signs of sepsis when the thrombosed
pseudoaneurysm became infected. He underwent
debridement of the head of the pancreas and external
drainage of the retroperitoneal abscess cavity.
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Thus, seven of 16 patients required combined
therapy. The technical success rate of the 13 surgical
interventions (10 as initial therapy and 3 after PAE)
was 69%, whereas the success rate for the 10 PAEs
was 60% (6 as initial therapy and 4 after surgery).
Morbidity. The surgical morbidity rate was 62%
(8 of 13) including the intraoperative failures (3),
acute respiratory distress syndromes (2), and post-
operative intracystic hemorrhage, intra-abdominal
fluid collection, and postoperative colocutaneous
fistula in one patient each (Table I). The overall PAE
morbidity rate, excluding technical failure, was 50%
(5 of 10). Of the three patients who underwent PAE
after unsuccessful operative attempts at bleeding
control, two patients (1 and 2) sustained proximal
intimal dissections during embolization attempts.
One patient, as previously noted, died; the other
patient (2) survived after a prolonged stay in the
intensive care unit and is alive at 48 months’ follow-
up. Coil migration occurred in two patients, which
resulted in one patient (5) without clinical sequelae,
but left the other patient (15) with a left hepatic
Table I. Patients treated with operation as first-line therapy
Patient Age (y) Sex Size Vessel Initial treatment
1 36 M 17 cm Splenic/GDA Marsupialization and external drainage; splenic
artery ligation. Persistent bleeding
2 50 F 7 cm GDA Right hemicolectomy for extrinsic compression; 
splenectomy. Persistent bleeding 
3 23 M 10 cm SMA Pancreatic debridement and external drainage, 
SMA ligation. Persistent bleeding
4 45 M 8 cm Splenic artery Splenic artery ligation, distal pancreatectomy, 
splenectomy
5 40 M 33 cm GDA Pancreatic debridement and external drainage, 
right hemicolectomy for extrinsic compression of 
pseudocyst on middle colic vessels. Intracystic 
hemorrhage on POD 30
6 67 F 14 cm GDA Hematoma evacuation from pancreatic head, 
GDA ligation 
7 39 M 16 cm Splenic vein Ligation of splenic vein, splenectomy, external 
drainage of pseudocyst
8 40 F 13 cm Unknown Roux-en-Y cystojejunostomy, thrombus evacuation
9 48 F 2 cm Unknown Distal pancreatectomy, splenectomy
10 43 M 10 cm Unknown Vessel ligation, external drainage of pseudocyst, 
pancreatic debridement
ARDS, Acute respiratory distress syndrome; CT, computed tomography; F, female; F/U, follow-up; GDA, gastroduodenal artery; 
LUQ, left upper quadrant; M, male; PAE, percutaneous arterial embolization; PDA, pancreaticoduodenal artery; POD, postoperative 
day; post-op, postoperatively; SMA, superior mesenteric artery. 
Table II. Patients treated with embolization as first-line therapy
Patient Age (y) Sex Size Vessel Initial treatment
11 59 M 8 cm PDA Attempted PAE: failure to cannulate
12 58 M 7 cm GDA PAE of GDA with coils
13 51 M 2.5 cm PDA PAE of PDA with Gelfoam
14 50 M 6 cm Splenic artery PAE of splenic artery with coils
15 52 F 5 cm GDA Failed PAE of GDA: persistent bleeding
16 34 M 6 cm GDA PAE of GDA with Gelfoam. Intra-abdominal sepsis
on POD 17
ARDS, Acute respiratory distress syndrome; CT, computed tomography; F/U, follow-up; GDA, gastroduodenal artery; PAE,
percutaneous arterial embolization; PDA, pancreaticoduodenal artery; POD, postoperative day. 
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lobar infarction (Fig 3). Infection of a thrombosed
pseudoaneurysm occurred in one patient (16) 17
days after PAE and required external drainage.
The need for surgical repair of the pseudo-
aneurysm. In addition to hemorrhage, other sec-
ondary complications such as infection or mass
effect mandated excisional therapy of the pseudocyst
in seven patients (44%). Infection of the pseudo-
aneurysm that required drainage in three patients
and colectomy in another was the most common
cause of operation, whereas extrinsic compression
that resulted in colonic ischemia, duodenal obstruc-
tion, and splenic rupture necessitated colectomy,
duodenal decompression, and splenectomy in one
patient each. The mean size of pseudoaneurysms
that required operative intervention for secondary
complications was 13.9 cm, compared with 7.7 cm
for all others in the series (P = .046). 
Late survival and follow-up. Complete follow-
up was available in 11 of 13 survivors at a mean
duration of 44 months (range, 1-108 months). Two
patients were lost to follow-up at 1 and 5 months.
Secondary treatment Morbidity Outcome Results of F/U CT 
Failed PAE of common hepatic artery: Death Death immediately post-op
dissection
Failed PAE of GDA, dissection of celiac axis ARDS, Chronic pancreatitis Pancreas atrophied, evidence 
Repeat angiography at 24 hours showed no wound at 48 mo of chronic pancreatitis at
bleeding dehiscence 40 mo
PAE of the right gastroepiploic artery Death Death immediately post-op
Death Death immediately post-op
PAE of GDA with coils Coil migration Pain free at 11 mo Resolution of pseudocyst at 
into right 7 mo
hepatic artery
Angiography showed GDA ligation without None Pain free at 130 mo
evidence for bleeding
Sterile fluid Chronic pancreatitis at 5 mo Pancreatitis, resolution of 
collection in pseudocyst at 1 mo
LUQ
None Chronic pancreatitis, pancreatic New pseudocyst, resolution 
insufficiency at 26 mo of old one at 18 mo
None Pain free at 20 mo
Colonic fistula Chronic pancreatitis at 16 mo Pancreatitis, resolution of 
in granulating pseudocyst at 6 mo
wound
Secondary treatment Morbidity Outcome Results of F/U CT 
Evacuation of hematoma compressing None. Pain free at 80 mo
duodenum, external drainage of cyst 
cavity, vessel ligation
None Pain free at 14 mo
None Pain free at 94 mo
None Mild pain at 1 mo Persistent pseudocyst at  
1 mo
Ligation of GDA, Roux-en-Y Coil migration, Pain free at 13 mo Resolution of pseudocyst at 
cystojejunostomy left hepatic lobar 12 mo
infarction
Pancreatic debridement, external drainage ARDS, sepsis Pain free at 108 mo Resolution of pseudocyst at 
of retroperitoneal abscess 13 mo
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Of the 11 patients, four (36%) had symptoms of
pancreatitis.
Follow-up CT scans were obtained in eight
patients at a mean interval of 12 months (range, 1-
40 months), which demonstrated resolution of the
original pseudoaneurysm in seven patients (Tables I
and II). In one patient, a decrease in the size of the
pseudoaneurysm from 6 to 2 cm was noted at 1
month after PAE. The development of a new 2.5-
cm pseudocyst was discovered at 18 months in a
patient who has alcoholism and chronic pancreatitis
and pancreatic insufficiency.
DISCUSSION
The current series is the largest in the literature
in which the early and late results after management
of pancreatitis-related visceral pseudoaneurysms are
described. The findings in this study have a couple
of implications. First, an operation and PAE have
complementary roles in the management of these
patients. PAE was successful as the initial treatment
for hemodynamically stable patients. An operation
was required for control of hemorrhage in hemody-
namically unstable patients, for failed embolization,
and for secondary complications such as infection
and extrinsic compression. Second, because the
development of secondary complications is likely to
occur with larger pseudoaneurysms, operative exci-
sion or a drainage procedure should be considered
after successful PAE.
The development of a pseudoaneurysm from
vessel wall erosion by a pseudocyst is due to uncon-
trolled, severe inflammation necrotizing the vessel
wall10 or enzymatic autodigestion of a pancreatic or
peripancreatic artery.11 If the pseudocyst has not yet
developed a thick wall, the pseudoaneurysm can
rupture into the retroperitoneum or freely into the
peritoneal cavity.12 The intense inflammatory
changes surrounding such a pseudoaneurysm make
surgical control extremely challenging with an asso-
ciated high death and complication rate. 
In several recent reports, PAE is advocated as
the sole therapy for the treatment of pancreatitis-
associated pseudoaneurysms with high technical
success rates (75%-100%) and low morbidity (14%-
25%) and death rates (0%-14%) (Table IV).13-17
Most of these reports, however, are limited by small
numbers of patients (3-14 each, 34 total) and short
follow-up period. Gambiez et al13 have the longest
follow-up on 14 patients who were treated with
PAE and surgical therapy. Observing no late recur-
rence of bleeding in a group of six patients treated
with PAE alone after a mean follow-up of 35
months, they recommended PAE as first-line thera-
py and the reservation of surgery for other sec-
ondary complications. Salam et al16 reported on 14
true visceral aneurysms and two pancreatitis-
induced pseudoaneurysms that were treated with
PAE with an 81% success rate; they advocated PAE
as the primary treatment modality. Huizinga et al15
documented four patients with hemorrhagic
pseudocysts who were treated with PAE alone with
Fig 1. A, CT scan demonstrating a 33-cm pseudoaneurysm that was treated with external drainage,
right hemicolectomy, and pancreatic debridement. B, The patient had sudden hemorrhage into the
drained cystic cavity from the GDA 29 days later, which underwent successful embolization.
A B
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no complications and no death; they suggested that
PAE may obviate the need for emergency surgery.
The findings of this study, however, do not sup-
port PAE alone as adequate therapy. PAE was associ-
ated with a high primary failure rate (2 [20%] of 10)
that required conversion to operative repair. PAE
failed to control hemorrhage during postoperative
attempts and caused dissection of visceral vessels in
another two patients. The combined failure rate of
40% with PAE does not support PAE as an adequate
sole therapy. Furthermore, successful PAE does not
address the possible need for drainage of the residual
thrombosed pseudoaneurysm. Of the eight patients
in this series who had follow-up CT scans, the only
patient who showed persistence of the pseudocyst
was one who had PAE without a drainage procedure.
The management of the thrombosed pseudo-
aneurysm after successful PAE remains contro-
versial.8,13,16 Some investigators have proposed that
no further treatment is necessary after successful PAE
of a pseudoaneurysm.8,9 Elton et al8 reported on
three patients who were successfully treated with
PAE and endoscopic drainage of the pseudocyst,
with short-term follow-up CT scans (2 and 6
months) in two patients demonstrating complete res-
olution of the pseudocyst.8 Huizinga et al15 obtained
follow-up ultrasound scan examinations (at 1 and 2
months) in two of the four patients who had no sur-
gical drainage, which showed the thrombosed
pseudocyst cavity “to be smaller,” although two of
the four also had recurrent pancreatitis. Success in six
patients after PAE alone prompted Gambiez et al13
Fig 2. A, Percutaneous arterial coil embolization of the GDA (curved arrow) for a 5-cm pancreatic
pseudoaneurysm (small arrow). Notice the persistent leak into the pseudoaneurysm through SMA col-
laterals (open arrow). B, CT scan 3 days later showing a persistent leak into the pseudoaneurysm. C,
Intraoperative photograph of the pseudoaneurysm (open arrows) of the GDA (encircled with a vessel
loop, solid arrow) near the head of the pancreas. The GDA was ligated, and a Roux-en-Y cystoje-
junostomy was performed.
A
CB
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to investigate the residual cystic cavities document-
ing that “the volume of the pseudocyst decreased in
all patients,” but no size information was given.
Inflammation of the thrombus-filled pseudo-
aneurysm, in conjunction with the possible persistence
of enzymatic degradation of peripancreatic tissue, may
result in continued growth or development of other
complications.18 It is widely accepted that any mature
pancreatic pseudocyst larger than 6 cm should be sur-
gically drained to prevent the development of sec-
ondary complications. Indeed, seven (44%) of 16
patients in the current series ultimately required a
pseudocyst/pseudoaneurysm drainage procedure for
secondary complications.
The mean size of pseudoaneurysms with sec-
ondary complications that required operative inter-
vention was significantly larger (13.9 cm) than those
without (7.7 cm). This would imply that the size is a
factor in determining the need for drainage, as stan-
dard surgical dictum states. We agree with de Perrot
et al19 who view PAE as a temporizing measure and
suggest that surgical drainage follow as soon as pos-
sible, particularly for larger pseudoaneurysms. The
findings in this series confirm an increased incidence
of complications with increasing size of the pseudo-
aneurysm. It seems reasonable to proceed with exci-
sion or a drainage procedure after PAE, particularly
when the pseudoaneurysm is large (> 10 cm).
The two identifiable factors associated with
death in this series were the presence of necrotizing
pancreatitis and the need for emergency surgery.
Increased morbidity and prolonged hospitalization
were also associated with necrotizing pancreatitis in
this series. Indeed, an operative complication rate as
high as 87% has been reported in this setting.20
Because most patients with necrotizing pancreatitis
are gravely ill, PAE may obviate the need for an
urgent operation or allow conversion of an emer-
gency into an elective operation.
The limitations of this study are the small num-
ber of patients and the inherent deficiencies of ret-
rospective review. The development of a pancreati-
tis-induced pseudoaneurysm is an unusual complica-
tion. Thus, it is difficult for a single institution to
gather a large experience in the management of this
problem. In fact, the current series is the largest in
the literature from a single institution. 
Long-term results after PAE for pancreatitis-
related pseudoaneurysms are scarce in the literature.
Several authors have documented recurrent hemor-
rhage after initially successful PAE.8,19,21,22 The
incidence of recanalization requiring repeat PAE for
visceral aneurysms and pseudoaneurysms was noted
to be 12% and 37% in two studies.16,21 In the cur-
rent series, no clinically significant recurrences were
detected at a mean of 44 months. Follow-up CT
Fig 3. A, Postoperative CT scan of the patient shown in
Fig 2 showing left hepatic lobe infarction due to coil
migration into the left hepatic artery. B, Follow-up CT
scan at 12 months shows partial regeneration and com-
pensatory hypertrophy of the right hepatic lobe.
A
B
Table III. Indications for surgery (n = 13)*
Intra-abdominal sepsis 4
Hemodynamic instability 4
Peritonitis 2
Pain 2
Splenic rupture 1
Duodenal compression 1
Hemorrhage uncontrolled by embolization 1
*Two patients had more than one indication.
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scans revealed no recurrent bleeding or pseudoa-
neurysm formation after PAE, with the resolution of
pseudoaneurysms documented in seven of eight
patients at a mean interval of 12 months. 
The management of visceral pseudoaneurysms
resulting from pancreatic pseudocysts remains a chal-
lenging problem with high morbidity and death.
Operation and PAE have complementary roles, and
the optimal approach is determined by patient pre-
sentation. PAE is recommended as the initial treat-
ment for hemodynamically stable patients. An opera-
tion should be reserved for actively bleeding, hemo-
dynamically unstable patients; for failed embolization;
and for other complications such as infection and
extrinsic compression. Operative drainage should be
considered after successful PAE to avoid the develop-
ment of secondary complications, particularly for
large pseudoaneurysms. Careful follow-up is neces-
sary because these patients frequently have pancreatic
insufficiency or a new pseudocyst.
REFERENCES
1. Gadacz TR, Kieffer RF, Trunkey D. Visceral vessel erosion
associated with pancreatitis. Arch Surg 1978;113:1438-40.
2. Stanley JC, Frey CF, Miller TA. Major arterial hemorrhage: a
complication of pancreatic pseudocysts and chronic pancre-
atitis. Arch Surg 1976;111:435-40.
3. El Hamel A, Parc R, Adda G, Bouteloup PY, Huguet C.
Bleeding pseudocysts and pseudoaneurysms in chronic pan-
creatitis. Br J Surg 1991;78:1059-63.
4. Stabile BE, Wilson SE, Debas HT. Reduced mortality from
bleeding pseudocysts and pseudoaneurysms caused by pan-
creatitis. Arch Surg 1983;118:45-51.
5. Coll DP, Ierardi R, Kerstein MD, Yost S, Wilson A,
Matsumoto T. Aneurysms of the pancreaticoduodenal arteries:
a change in management. Ann Vasc Surg 1998;12:286-91.
6. Sankaran S, Walt S. The natural and unnatural history of pan-
creatic pseudocysts. Br J Surg 1975;62:37-9.
7. Kiviluoto T, Kivisaari L, Kivilaakso E. Pseudocysts in chronic
pancreatitis: surgical results in 102 consecutive patients. Arch
Surg 1989;124:240-3.
8. Elton E, Howell DA, Amberson SM, Dykstra D. Combined
angiographic and endoscopic management of bleeding pancre-
atic pseudoaneurysms. Gastrointest Endosc 1997;46:544-9.
9. Mauro MA, Jaques PF. Transcatheter management of
pseudoaneurysms complicating pancreatitis. J Vasc Interv
Radiol 1991;2:527-32.
10. Stroud WH, Cullom JW, Anderson MD. Hemorrhagic com-
plications of severe pancreatitis. Surgery 1981;90:657-65.
11. Bresler L, Boissel P, Grosdidier J. Major hemorrhage from
pseudocysts and pseudoaneurysms caused by chronic pancre-
atitis: surgical therapy. World J Surg 1991;15:649-53.
12. Bender JS, Bouwman DL, Levison MA, Weaver DW.
Table IV. Death and complication rates in literature
Author Year Total patients Therapy Patients Mortality Complications
de Perrot15 1999 10 Embolization 3 33% (1/3) 1 recurrent hemorrhage/death
Surgery 7 14% (1/7) 2 subphrenic abscesses
Gambiez13 1997 14 Embolization 14 7% (1/14) 3 embolization failed to control 
hemorrhage
1 duodenal necrosis
1 aortic thrombosis/death
Surgery 8 13% (1/8) 1 death
1 subphrenic abscess
1 septicemia
Eckhauser20 1980 7 Surgery 7 43% (3/7) 3 sepsis/death
El Hamel3 1991 15 Surgery 15 13% (2/15) 1 hepatic failure/death
1 recurrent hemorrhage/death
2 recurrent hemorrhages
Sand18 1997 8 Embolization 6 0% (0/6) 1 elevated liver function tests
1 pseudocyst infection
Surgery 2 0% (0/2) None
Stabile4 1983 8 Embolization 2 0% (0/2) 1 failure to control hemorrhage
Surgery 8 13% (1/8) 1 failure to control hemorrhage
1 sepsis/death
Elton7 1997 3 Embolization 3 0% (0/3) 1 recurrent hemorrhage
Stroud10 1981 7 Surgery 7 29% (2/7) 1 hepatic failure/death
1 pancreatic necrosis/death
Bresler11 1991 10 Surgery 10 10% (1/10) 1 sepsis/death
Bender12 1995 8 Surgery 8 13% (1/8) 1 hemorrhage/shock/death
Huizinga15 1984 4 Embolization 4 0% (0/4) 1 Gelfoam migration
1 hepatic artery branch occlusion
Marshall17 1996 5 Embolization 5 0% (0/5) 1 access failure
1 angiogram failed to show bleeding
Surgery 4 0% (0/4) None
Comparison of mortality and complications between embolization and surgery to control hemorrhage from pancreatitis-associated
pseudoaneuryms in 12 case series in the literature.
JOURNAL OF VASCULAR SURGERY
730 Carr et al October 2000
Pseudocysts and pseudoaneurysms: surgical strategy.
Pancreas 1995;10:143-7.
13. Gambiez LP, Ernst OJ, Merlier OA, Porte HL. Arterial
embolization for bleeding pseudocysts complicating chronic
pancreatitis. Arch Surg 1997;132:1016-21.
14. Stambo GW, Hallisey MJ, Gallagher JJ Jr. Arteriographic
embolization of visceral artery pseudoaneurysms. Ann Vasc
Surg 1996;10:476-80.
15. Huizinga WK, Kalideen JM, Bryer JV, Bell PS, Baker LW.
Control of major haemorrhage associated with pancreatic
pseudocysts by transcatheter arterial embolization. Br J Surg
1984;71:133-6.
16. Salam TA, Lumsden AB, Martin LG, Smith RB III.
Nonoperative management of visceral aneurysms and
pseudoaneurysms. Am J Surg 1992;164:215-9.
17. Marshall GT, Howell DA, Hansen BL, Anderson SM,
Abourjaily GS, Bredenberg CE. Multidisciplinary approach
to pseudoaneurysms complicating pancreatic pseudocysts.
Arch Surg 1996;131:278-83.
18. Sand JA, Seppanen SK, Nordback IH. Intracystic hemor-
rhage in pancreatic pseudocysts: initial experiences of a treat-
ment protocol. Pancreas 1997;14:187-91.
19. de Perrot M, Berney T, Buhler L. Management of bleeding
pseudoaneurysms in patients with pancreatitis. Br J Surg
1999;86:29-32.
20. Eckhauser FE, Stanley JC, Zelenock GB, Borlaza GS.
Gastroduodenal and pancreaticoduodenal artery aneurysms:
a complication of pancreatitis causing spontaneous gastroin-
testinal hemorrhage. Surgery 1980;88:335-44.
21. Boudghene F, L’hermine C, Bigot JM. Arterial complica-
tions of pancreatitis: diagnostic and therapeutic aspects in
104 cases. J Vasc Interv Radiol 1993;4:551-8.
22. Lee MJ, Saini S, Geller SC. Pancreatitis with pseudoa-
neurysm formation: a pitfall for the interventional radiolo-
gist. AJR Am J Roentgenol 1991;156:97-8.
Submitted Mar 23, 2000; accepted Jun 21, 2000.
DISCUSSION
Dr Kenneth E. McIntyre (Dallas, Tex). Our invited
discussant Dr Tim Harward was unable to join us this
morning and has forwarded me a copy of his discussion.
Acute hemorrhage associated with pancreatic pseudo-
aneurysms is the most rapidly fatal complication of pancre-
atitis and has a reported mortality rate of greater than 90%. 
Historically, surgeons have been called upon to dra-
matically attempt to deal with these patients in the operat-
ing room under very adverse conditions. More recently,
our colleagues, the interventional radiologists, have joined
the battle using catheters and embolizing devices. In fact,
the radiologists have become so efficient at these tech-
niques that surgeons have become complacent believing
that catheter-direct embolization alone can solely deal with
this problem. Dr Cho and his colleagues have very nicely
demonstrated that this belief is far from true. In fact, in this
series 13 patients required surgical intervention, frequent-
ly after attempted catheter-directed embolization.
These were his comments and questions. In reviewing
your paper I noticed that 10 patients underwent surgical
intervention as their first-line therapy versus only six
patients undergoing radiologically attempted emboliza-
tion. What was the reason for this overabundance of sur-
gical procedures compared to radiologic procedures? Is it
partially related to the experience of your radiologic staff
in the early years of the study with more radiologic proce-
dures being done first in the latter years of the study as
radiologic techniques became more refined?
Two, in both your study and many of the reports in
the literature, there appears to be a definite problem of
leaking several weeks after the acute leak has been stopped
by embolization techniques. In this clinical situation, some
radiologists have suggested that steel coils are the emboliz-
ing agent of choice for the management of pancreatitis-
associated pseudoaneurysm. It is theorized that the
Gelfoam is digested by enzymes leading to delayed hemor-
rhage into the pseudocyst in chronic pancreatitis while a
small percentage have acute hemorrhage from coil migra-
tion. In addition, we can say necrotizing pancreatitis versus
chronic pancreatitis is much more difficult to deal with and
has a higher complication rate and why is this so?
Dr John Carr. Thank you Dr McIntyre for conveying Dr
Harward’s comments. Concerning the first question about
the 10 patients who required surgical intervention, the indi-
cation for those interventions was hemodynamic instability
in six patients and acute abdominal findings in four. We
chose the period of time from 1988 to 1998 because that
was when embolization was commonly in use at our insti-
tution and we feel that the sample population is selective. 
Concerning rebleeding, with the use of steel coils ver-
sus Gelfoam, in our series we did have two migrations of
the coils. Both of those were steel coils in two out of four
patients. The three patients who had the use of Gelfoam
did not have any subsequent migration of the embolic
material. The use of hydrogels, I do not believe, has been
approved for this indication. However, there is an inci-
dence of Gelfoam being digested with recannalization of
the vessel within several months after its use. So in a way
a balance has to be achieved between the permanency of
steel coils yet counter balanced by maybe a higher risk of
embolization or migration. 
In response to the last question concerning necrotiz-
ing pancreatitis versus chronic pancreatitis, there does
appear to be a theoretical higher chance of perforating a
vessel during a cannulation through percutaneous tech-
niques if the vessel is inflamed with the necrotizing pan-
creatitis. However, this did not occur in any of our
patients, and I think it is only a theoretical risk. Despite
that, the ease of cannulation and embolization does not
appear to be affected by the process.
